ClinicalTrials.gg
Drug

Tasquinimod clinical trials

Also written ABR-215050.

studies test it
11
open now
2
in phase 3
2
first study started
2007

How each study uses tasquinimod is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the tasquinimod studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tasquinimod
10

Development codes

ABR-215050
4

Studies by the year they started

11 studies that test it; most in 2012 (2)

Studies that test tasquinimod, by start year
YearStudies
20071
20091
20111
20122
20131
20141
20151
20201
20241
20251

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
5
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 6 · Other 5

Ipsen (3) · Active Biotech AB (3) · Andrew J. Armstrong, MD (1) · M.D. Anderson Cancer Center (1) · Stichting Hemato-Oncologie voor Volwassenen Nederland (1) · University of Pennsylvania (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

Studies

Open first, then newest update. How each study uses tasquinimod is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 11

Given beside what is tested · 1 — tasquinimod is usual care or a partner of the new treatment

Codes

What other systems call tasquinimod · ClinicalTrials.gg INT005019

  • MeSH (NLM) C516109tasquinimodConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 756U07KN1RTASQUINIMODConfirmed FDA, NLM, Wikidata
  • Wikidata Q7687612tasquinimodConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C74080TasquinimodOne source FDA
  • DrugBank DB05861One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.